NovoCure Limited (NVCR)
NASDAQ: NVCR · Real-Time Price · USD
11.30
-0.53 (-4.48%)
At close: Nov 16, 2026, 4:00 PM EST
11.83
+0.53 (4.70%)
Pre-market: Nov 17, 2026, 8:18 AM EST

NovoCure Revenue

NovoCure had revenue of $193.40M in the quarter ending September 30, 2026, with 15.67% growth. This brings the company's total for the last twelve months to $725.39M, up 12.94% year-over-year. In the year 2025, NovoCure had annual revenue of $655.35M with 8.28% growth. That makes NovoCure the 9,230th largest company in the world by revenue and 2,048th in the United States.

Revenue (ttm)
$725.39M
Revenue Growth
+12.94%
P/S Ratio
1.82
Revenue / Employee
$451,955
Employees
1,605
Market Cap
1.32B

Revenue Chart

Revenue by Geography

  • United States 385.63M 58.8%
  • Germany 79.41M 12.1%
  • France 76.19M 11.6%
  • Other International Markets 56.90M 8.7%
  • Japan 37.79M 5.8%
  • Greater China 19.44M 3.0%
Fiscal year ended Dec 31, 2025 See the full NovoCure breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025655.35M50.13M8.28%
Dec 31, 2024605.22M95.88M18.82%
Dec 31, 2023509.34M-28.50M-5.30%
Dec 31, 2022537.84M2.81M0.53%
Dec 31, 2021535.03M40.67M8.23%
Dec 31, 2020494.37M143.05M40.72%
Dec 31, 2019351.32M103.25M41.62%
Dec 31, 2018248.07M71.04M40.13%
Dec 31, 2017177.03M94.14M113.57%
Dec 31, 201682.89M49.80M150.52%
Dec 31, 201533.09M17.60M113.60%
Dec 31, 201415.49M5.13M49.53%
Dec 31, 201310.36M--